Search results
NeuroSense Partners with PhaseV to Optimize Upcoming ALS Phase 3 Trial Using Advanced Causal Machine...
WJTV Jackson· 2 days agoNeuroSense Therapeutics (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today announced that ...
New biomarker identified to diagnose Alzheimer's in asymptomatic stages
Medical Xpress· 16 hours agoMolecular Basis of Disease. The search for biomarkers that are stable and easily detectable in...
A Brain Breakthrough 25 Years in the Making
The Scientist· 2 days agoThe patient had spinocerebellar ataxia type 4 (SCA4), a progressive neurodegenerative disease that causes muscle weakness, movement difficulty, and loss...
Coya Therapeutics Reports First Quarter 2024 Financial Results
Guru Focus· 5 days agoThe Houston-based clinical-stage biotechnology company reported a net loss of $5.1 million, which did not align with analyst expectations of a $4.43 million loss. Coya Therapeutics is at the ...
Scientists unravel genetic basis for neurodegenerative disorders that affect vision
Medical Xpress· 14 hours agoPublished in the journal Brain, the research offers a deeper understanding of PNPLA6-related conditions at clinical, genetic, and molecular levels, paving the way for tailored diagnostic and ...
Psychological therapy shows promise in improving quality of life for people living with motor neuron...
Medical Xpress· 6 days agoMND is a progressive, neurodegenerative disease with no cure. It affects motor neurons, which are...
Analyst Report: Lilly(Eli) & Co
Argus Research via Yahoo Finance· 2 days agoEli Lilly, based in Indianapolis, develops and manufactures therapies to treat pain, diabetes, cancer, and neurodegenerative diseases. The shares are a component of the S&P 500.
Research sheds light on how proteins linked to Alzheimer's disease influence neuronal growth
Medical Xpress· 1 day agoA new study led by the University of Exeter and published in Open Biology has discovered the key...
Earnings call: Quanterix sees 13% revenue growth in Q1 2024, driven by lab services By Investing.com
Investing.com· 7 days agoQuanterix (NASDAQ:QTRX) Corporation (ticker: QTRX), a company specializing in the development of...
The five worst ultra-processed foods you need to avoid
Yahoo Life UK· 6 days ago(Getty Images) Getty In the years that followed, scientists identified 48,193 deaths from cancer,...